1. Home
  2. AGPU vs ACXP Comparison

AGPU vs ACXP Comparison

Compare AGPU & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AGPU

Axe Compute Inc. Common Stock

N/A

Current Price

$1.88

Market Cap

6.9M

Sector

N/A

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.50

Market Cap

6.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGPU
ACXP
Founded
2002
2017
Country
United States
United States
Employees
24
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
6.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
AGPU
ACXP
Price
$1.88
$1.50
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$143.67
AVG Volume (30 Days)
67.7K
48.1K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
24.35
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$486.27
N/A
Revenue Next Year
$65.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.29
52 Week High
$9.00
$8.34

Technical Indicators

Market Signals
Indicator
AGPU
ACXP
Relative Strength Index (RSI) 31.98 23.69
Support Level N/A $0.31
Resistance Level $2.51 $2.89
Average True Range (ATR) 0.32 0.17
MACD 0.09 -0.01
Stochastic Oscillator 1.66 11.39

Price Performance

Historical Comparison
AGPU
ACXP

About AGPU Axe Compute Inc. Common Stock

Axe Compute Inc functions as an active infrastructure operator. The company intends to expand access to AI compute resources by utilizing the Aethir network, which provides scalable, cost-efficient cloud GPU services for AI, machine learning, gaming, and rendering applications. Through the use of Aethir's decentralized international infrastructure, it aims to provide access to bare-metal GPUs at scale for both emerging and established organizations. It plans to monetize access to the network by serving enterprise customers that require guaranteed capacity, service-level agreements, and a counterparty operating within conventional corporate and regulatory frameworks.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.

Share on Social Networks: